Testing for ALK-positive NSCLC.
The American journal of managed care
View on PubMed
Non-Small Cell Lung Carcinoma
Sorry, we couldn't extract any citations for this paper.
Sorry, we couldn't extract any references for this paper.
Loading similar papers…
Presentations referencing similar topics
Crizotinib in Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Heather Wakelee • Sep 26, 2017
Results of a Global Phase II Study with Crizotinib in Advanced ALK-positive Non-small Cell Lung Cancer ( NSCLC )
G. J. Riely + 8 • Sep 26, 2017
Molecular Testing Guideline Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
Neal I Lindeman • Oct 17, 2017